$CRBU 4 SEC Filings

Filed On	Filing
27 Feb 2026	Form 4: Kelly Timothy P, Chief Technology Officer Sold 6,228 shares ($12K)
24 Feb 2026	Form 4: Kelly Timothy P, Chief Technology Officer Received 45,000 shares as a grant or award · Granted 202,500 Option to purchase Common Stock · Sold 3,147 shares ($6.17K)
24 Feb 2026	Form 4: Mcclung Barbara G, Chief Legal Officer Received 45,000 shares as a grant or award · Granted 202,500 Option to purchase Common Stock · Sold 6,938 shares ($13.6K)
24 Feb 2026	Form 4: Khan Ruhi Ahmad, Chief Business Officer Received 45,000 shares as a grant or award · Granted 202,500 Option to purchase Common Stock · Sold 6,938 shares ($13.6K)
24 Feb 2026	Form 4: Albertson Tina M., Chief Medical Officer Received 55,000 shares as a grant or award · Granted 247,500 Option to purchase Common Stock · Sold 1,066 shares ($2.09K)
20 Feb 2026	Form 4: Richardson-Heron Dara, Director Granted 45,000 Option to purchase Common Stock
20 Feb 2026	Form 4: Zheng Ran, Director Granted 45,000 Option to purchase Common Stock
20 Feb 2026	Form 4: Whiting Nancy, Director Granted 45,000 Option to purchase Common Stock
20 Feb 2026	Form 4: Johnson David Lee, Director Granted 45,000 Option to purchase Common Stock
20 Feb 2026	Form 4: Guggenhime Andrew, Director Granted 45,000 Option to purchase Common Stock
20 Feb 2026	Form 4: Braunstein Scott, Director Granted 45,000 Option to purchase Common Stock
20 Feb 2026	Form 4: Ryali Sriram, Chief Financial Officer Received 55,000 shares as a grant or award · Granted 247,500 Option to purchase Common Stock
20 Feb 2026	Form 4: Sacks Natalie, Director Granted 45,000 Option to purchase Common Stock
20 Feb 2026	Form 4: Haurwitz Rachel E., Director Received 151,700 shares as a grant or award · Granted 682,500 Option to purchase Common Stock
17 Mar 2025	Form 4: Haurwitz Rachel E., Director Bought 20,000 shares ($20.4K)
21 Feb 2025	Form 4: Albertson Tina M., Chief Medical Officer Received 14,589 shares as a grant or award · Granted 66,137 Option to purchase Common Stock
21 Feb 2025	Form 4: Haurwitz Rachel E., Director Received 136,750 shares as a grant or award · Granted 618,250 Option to purchase Common Stock
21 Feb 2025	Form 4: Mcclung Barbara G, Chief Legal Officer Received 37,500 shares as a grant or award · Granted 170,000 Option to purchase Common Stock · Sold 3,564 shares ($4.81K)
21 Feb 2025	Form 4: Khan Ruhi Ahmad, Chief Business Officer Received 37,500 shares as a grant or award · Granted 170,000 Option to purchase Common Stock · Sold 3,564 shares ($4.81K)
21 Feb 2025	Form 4: Kelly Timothy P, Chief Technology Officer Received 37,500 shares as a grant or award · Granted 170,000 Option to purchase Common Stock

Comments